Atlas Trials

Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma

Clinical trial NCT04988841 · COMPLETED

Trial details

NCT number
NCT04988841
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2022-01-20
Primary completion
2024-08-30
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.